(Q28268420)

1

0 references

David Engelmann

2

0 references

Annett Niemetz

3

0 references

Jens Pahnke

4

0 references

Anke Schmidt

5

0 references

Manfred Kunz

6

0 references

Stephan Emmrich

7

0 references

Marc Steder

8

0 references

Dirk Koczan

9

0 references

Brigitte M Pützer

Journal of the National Cancer Institute

10

0 references

language of work or name

English

0 references

publication date

20 January 2010

0 references

published in

0 references

volume

102

0 references

issue

2

0 references

page(s)

127-33

0 references

cites work

Rb function in cell-cycle regulation and apoptosis

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Multiple members of the E2F transcription factor family are the products of oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Increased gene copy number of the transcription factor E2F1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Deregulated E2F transcriptional activity in autonomously growing melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Alterations of DeltaTA-p 73 splice transcripts during melanoma development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Role of the p53-homologue p73 in E2F1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

The role of the EGFR signaling in tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

An E2F1-dependent gene expression program that determines the balance between proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

Apaf-1 is a mediator of E2F-1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP458

release_drm77z77ubcxjim2hj6ygr6wmm

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJP458

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/drm77z77ubcxjim2hj6ygr6wmm